Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Asaka

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Diagnosis & Prognosis|September 6, 2024
Disproportionality Analysis of Osimertinib-related Adverse Events in Elderly Patients Using the Japanese Pharmacovigilance DatabaseTakashi Omoto, Junichi Asaka, Kenzo Kudo
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 6, 2026
Usefulness of the Risk Management Plan (RMP) Pocket Edition in Pharmacists' Practice in Community Pharmacies: A Questionnaire-Based StudyTakashi Omoto, Manato Inagaki, Junichi Asaka, et al.
Journal of Pharmaceutical Health Care and Sciences|September 30, 2025
External validation and comparison of clinical prediction models for cisplatin-associated acute kidney injury: a single-centre retrospective studyKazuki Saito, Satoru Nihei, Junichi Asaka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2023
Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodoneTakashi Omoto, Junichi Asaka, Satoru Nihei, et al.
In Vivo (Athens, Greece)|April 28, 2025
Adverse Reactions With VEGF Inhibitors in Combination With NSAIDs: Disproportionality Analysis Using JADRE and FAERSKazuki Saito, Satoru Nihei, Junichi Asaka, et al.
International Journal of Nephrology|December 16, 2021
Bevacizumab Increases Endothelin-1 Production via Forkhead Box Protein O1 in Human Glomerular Microvascular Endothelial Cells In VitroSatoru Nihei, Junichi Asaka, Hiroaki Takahashi, et al.
International Journal of Nephrology|October 23, 2025
Updating Predictive Model for Cisplatin-Induced Acute Kidney Injury: Incorporating Concomitant Medications and the Standard Supportive CareKazuki Saito, Satoru Nihei, Junichi Asaka, et al.
Journal of Pharmaceutical Health Care and Sciences|December 19, 2024
Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective studyTatsuki Ikeda, Satoru Nihei, Kazuki Saito, et al.
Journal of Pharmaceutical Health Care and Sciences|August 23, 2024
Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort studySatoru Nihei, Junichi Asaka, Mizunori Yaegashi, et al.
Biological & Pharmaceutical Bulletin|May 6, 2021
Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) DatabaseTakashi Omoto, Junichi Asaka, Takamasa Sakai, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Diagnosis & Prognosis|September 6, 2024
Disproportionality Analysis of Osimertinib-related Adverse Events in Elderly Patients Using the Japanese Pharmacovigilance DatabaseTakashi Omoto, Junichi Asaka, Kenzo Kudo
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 6, 2026
Usefulness of the Risk Management Plan (RMP) Pocket Edition in Pharmacists' Practice in Community Pharmacies: A Questionnaire-Based StudyTakashi Omoto, Manato Inagaki, Junichi Asaka, et al.
Journal of Pharmaceutical Health Care and Sciences|September 30, 2025
External validation and comparison of clinical prediction models for cisplatin-associated acute kidney injury: a single-centre retrospective studyKazuki Saito, Satoru Nihei, Junichi Asaka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2023
Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodoneTakashi Omoto, Junichi Asaka, Satoru Nihei, et al.
In Vivo (Athens, Greece)|April 28, 2025
Adverse Reactions With VEGF Inhibitors in Combination With NSAIDs: Disproportionality Analysis Using JADRE and FAERSKazuki Saito, Satoru Nihei, Junichi Asaka, et al.
International Journal of Nephrology|December 16, 2021
Bevacizumab Increases Endothelin-1 Production via Forkhead Box Protein O1 in Human Glomerular Microvascular Endothelial Cells In VitroSatoru Nihei, Junichi Asaka, Hiroaki Takahashi, et al.
International Journal of Nephrology|October 23, 2025
Updating Predictive Model for Cisplatin-Induced Acute Kidney Injury: Incorporating Concomitant Medications and the Standard Supportive CareKazuki Saito, Satoru Nihei, Junichi Asaka, et al.
Journal of Pharmaceutical Health Care and Sciences|December 19, 2024
Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective studyTatsuki Ikeda, Satoru Nihei, Kazuki Saito, et al.
Journal of Pharmaceutical Health Care and Sciences|August 23, 2024
Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort studySatoru Nihei, Junichi Asaka, Mizunori Yaegashi, et al.
Biological & Pharmaceutical Bulletin|May 6, 2021
Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) DatabaseTakashi Omoto, Junichi Asaka, Takamasa Sakai, et al.
Pageof 2